Skip to main content
. 2017 Aug 23;60(11):2192–2199. doi: 10.1007/s00125-017-4299-y

Table 3.

Incidence of all-cause, cardiovascular-, cancer- and diabetes-related mortality, and CVD events, in individuals with diabetes, by screening group (2001 to 2012)

Variable Screening group (n = 13,992) No-screening group (n = 125,083) Crude HR (95% CI) Adjusted HRa (95% CI)
Number of events Person-years follow-up Rate per 1000 person-years (95% CI) Number of events Person-years follow-up Rate per 1000 person-years (95% CI)
All-cause mortality 1775 97,265 18.2 (17.4, 19.1) 19,739 801,019 24.6 (24.3, 25.0) 0.71 (0.68, 0.75) 0.79 (0.74, 0.84)
Cardiovascular mortality 509 97,265 5.2 (4.8, 5.7) 5835 801,019 7.3 (7.1, 7.5) 0.70 (0.64, 0.77) 0.80 (0.72, 0.88)
Cancer mortality 954 97,265 9.8 (9.2, 10.5) 9546 801,019 11.9 (11.7, 12.2) 0.79 (0.74, 0.84) 0.83 (0.77, 0.89)
Diabetes-related mortality 121 97,265 1.2 (1.0, 1.5) 1701 801,019 2.1 (2.0, 2.2) 0.57 (0.48, 0.69) 0.66 (0.54, 0.81)
Composite cardiovascular event (first of CVD death, non-fatal IHD or non-fatal stroke) 2854 86,317 33.1 (31.9, 34.3) 28,487 698,893 40.8 (40.3, 41.2) 0.78 (0.75, 0.81) 0.84 (0.80, 0.89)

aHRs were estimated with a Cox proportional hazards regression model. Robust standard errors were calculated that take into account the two-level structure of the data and any potential correlation between individuals within practices

Models were adjusted for age, sex, education and prevalent chronic disease (IHD, stroke, cancer); baseline hazards were stratified by county